<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="122818">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02067572</url>
  </required_header>
  <id_info>
    <org_study_id>Salvia</org_study_id>
    <nct_id>NCT02067572</nct_id>
  </id_info>
  <brief_title>A Randomized Controlled Trial Evaluating the Effectiveness of a Salvia-based Mouthwash in Palliative Care</brief_title>
  <official_title>A Comparison of the Effectiveness of Normal Saline Mouthwash and Mouthwash Based on Tea Solution From Salvia Officinalis (SO) in Palliative Care. A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lovisenberg Diakonale Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Oslo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Lovisenberg Diakonale Hospital</source>
  <oversight_info>
    <authority>Norway: Regional Ethics Commitee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study examines the effectiveness of an herbal mouthwash made from salvia in maintaining
      good oral health among patients in palliative care. It is hypothesized that using the
      mouthwash made from salvia will result in better oral health and more oral comfort than
      using with conventional normal saline mouthwash.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to examine the effectiveness of an herbal mouthwash made from
      salvia officinalis (SO) in maintaining good oral health among patients in palliative care.
      The study compares a mouthwash based on salvia tea solution with conventional normal saline
      mouthwash and addresses the following research questions:

        1. Does the SO-based mouthwash provide a better treatment than conventional normal saline
           in maintaining good oral health in terminally ill patients?

        2. Is there a difference in the individual perception of oral comfort in patients
           receiving SO versus patients receiving saline rinsing solution?
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Oral health</measure>
    <time_frame>after 4 days of using mouthwash</time_frame>
    <safety_issue>No</safety_issue>
    <description>Oral Mucositis Assessment Scale (OMAS)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient's perception of oral comfort</measure>
    <time_frame>after 4 days of using mouthwash</time_frame>
    <safety_issue>No</safety_issue>
    <description>Questions regarding oral discomfort and EORTC - OH17</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oral health</measure>
    <time_frame>after 4 days of using mouthwash</time_frame>
    <safety_issue>No</safety_issue>
    <description>Clinical evaluation by dentist</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>General symptom experience</measure>
    <time_frame>after 4 days of using mouthwash</time_frame>
    <safety_issue>No</safety_issue>
    <description>Edmonton Symptom Assessment System (ESAS)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">88</enrollment>
  <condition>Terminal Illness</condition>
  <condition>Xerostomia</condition>
  <arm_group>
    <arm_group_label>Salvia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Salvia mouthwash used 4 times per day for 4 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Saline mouthwash used 4 times per day for 4 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Saline mouthwash</intervention_name>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Salvia mouthwash</intervention_name>
    <arm_group_label>Salvia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Attending bedded unit at Hospice

          -  Over 18 years of age and able to provide written formal consent

          -  Diagnosed with advanced cancer

          -  Patient with positive response when asked if they experience oral discomfort or
             complications.

        Exclusion Criteria:

          -  Estimated life expectancy prognosis of less than 2 weeks

          -  Significant cognitive impairment

          -  Current use of antifungal medication

          -  Currently receiving radiation therapy or chemotherapy

          -  Epileptic

          -  Diabetic
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anners Lerdal, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lovisenberg Diakonale Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anners Lerdal, PhD</last_name>
    <phone>+47 95033144</phone>
    <email>anners.lerdal@medisin.uio.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ragnhild Monsen, RN</last_name>
    <phone>+47 23225150</phone>
    <email>ragnhild.monsen@lds.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Lovisenberg Hospice</name>
      <address>
        <city>Oslo</city>
        <zip>0440</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Ragnhild Monsen, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 19, 2014</lastchanged_date>
  <firstreceived_date>February 18, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>oral health</keyword>
  <keyword>mouthwash</keyword>
  <keyword>salvia</keyword>
  <keyword>hospice</keyword>
  <keyword>xerostomia</keyword>
  <keyword>mouth sores</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Xerostomia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
